Upper urinary tract transitional cell carcinoma: Is there a best?

Clinical Genitourinary Cancer

Volumn 11, Issue 1, 2013, Pages 39-44

  Gunay, Levent Mert ^a   Akdogan, Bulent ^b   Koni, Artan ^b   Inci, Kubilay ^b   Bilen, Cenk Yucel ^b   Ozen, Haluk ^b  

^a Mersin Ozel Sistem Cerrahi Tip Merkezi   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Nephroureterectomy; Recurrence; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

CISPLATIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ANEMIA; ARTICLE; BLADDER CANCER; BLOOD CELL COUNT; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CLINICAL DECISION MAKING; CYSTECTOMY; CYSTOSCOPY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION TEST; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; NEPHROURETERECTOMY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURGICAL APPROACH; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR LOCALIZATION; URINARY TRACT CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; URETER; UROLOGIC NEOPLASMS;

EID: 84874545072     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2012.08.009     Document Type: Article

References (21)

1. G. Novara, V. De Marco, O. Dalpiaz Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract BJU Int 101 2008 1368 1374
2. M.D. Azémar, E. Comperat, F. Richard Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance Urol Oncol 29 2009 130 136
3. B. Akdogan, H.S. Dogan, S.Y. Eskicorapci Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma J Urol 176 2006 48 52
4. T. Hisataki, N. Miyao, N. Masumori Risk factors for the development of bladder cancer after upper tract urothelial cancer Urology 55 2000 663 667
5. F. Koga, H. Nagamatsu, H. Ishimaru Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract Urol Int 67 2001 135 141
6. C.H. Kang, T.J. Yu, H.H. Hsieh The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract Cancer 98 2003 1620 1626
7. M. Mullerad, P. Russo, D. Golijanin Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma J Urol 172 2004 2177 2181
8. Y. Matsui, N. Utsunomiya, K. Ichioka Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract Urology 65 2005 279 283
9. J.D. Raman, C.K. Ng, S.A. Boorjian Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology BJU Int 96 2005 1031 1035
10. J. Akao, H. Matsuyama, Y. Yamamoto Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors Clin Cancer Res 12 2006 7004 7008
11. J.Y. Joung, S.O. Yang, I.G. Jeong Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors Urol Int 81 2008 306 311
12. O. Kamihira, R. Hattori, A. Yamaguchi Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan Eur Urol 55 2009 1397 1407
13. M. Ploeg, K.K. Aben, C.A. Hulsbergen-van de Kaa Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands cancer registry J Urol 183 2010 915 920
14. R.P. Huben, A.M. Mounzer, G.P. Murphy Tumor grade and stage as prognostic variables in upper tract urothelial tumors Cancer 62 1988 2016 2020
15. V. Margulis, S.F. Shariat, S.F. Matin Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration Cancer 115 2009 1224 1233
16. Y.S. Song, J.S. Cho, K.S. Cho Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: A comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract Urol Int 85 2010 47 51
17. S.E. Lee, S.S. Byun, Y.H. Park Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract Urol Int 77 2006 22 26
18. A. Bamias, Ch Deliveliotis, G. Fountzilas Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group J Clin Oncol 22 2004 2150 2154
19. J. Bellmunt, T.K. Choueiri, R. Fougeray Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens J Clin Oncol 28 2010 1850 1855
20. E.C. Skinner, J.P. Stein, D.G. Skinner Surgical benchmarks for the treatment of invasive bladder cancer Urol Oncol 25 2007 66 71
21. M. Roscigno, S.F. Shariat, V. Margulis Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy J Urol 181 2009 2482 2489